Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Apr 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The CARTA study is looking at new ways to map a specific area of the brain called the ventral anterior temporal lobe (vATL) in patients with drug-resistant epilepsy. This type of epilepsy does not respond to standard medications, and some patients may be candidates for surgery to remove the part of the brain causing their seizures. However, it's important to identify critical areas in the brain that help with functions like naming things and recognizing faces, as removing these areas can lead to problems even if seizures stop. The study will use advanced brain imaging techniques to better visualize the vATL, which could help predict how well a patient will do after surgery.
To be eligible for this study, participants must be adults with epilepsy that doesn’t respond to medication and who are considering surgery, or healthy volunteers without any issues related to the anterior temporal lobe. Participants will undergo a special type of brain scan that uses innovative methods to improve the clarity of the images, allowing researchers to see important brain functions better. This research could help shape future treatments for epilepsy patients by enhancing surgical planning and improving outcomes after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult person,
- • Person affiliated to a social security scheme or beneficiary of such a scheme,
- • Person having received complete information on the organization of the Clinical Investigation and having signed informed consent,
- • Person having carried out a preliminary clinical examination adapted to the Clinical Investigation,
- • For patients: Person with drug-resistant structural focal epilepsy of the anterior temporal lobe (right or left), candidate for epilepsy surgery (anterior temporal lobectomy),
- • For healthy volunteers: Person with no known pathology in the anterior temporal lobe (particularly epilepsy).
- Exclusion Criteria:
- • Contraindication to MRI including claustrophobia,
- • Uncorrected visual disturbances,
- • Person unable to give consent,
- • Lack of mastery of the French language or ability to understand instructions,
- • Person referred to in Articles 64, 65 and 66 of European Regulation 2017/745: Person of full age unable to consent alone to participate in the Clinical Investigation; Minor; Pregnant or breastfeeding woman.
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nancy, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials